First Turn Management »

Axsome Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 295k 79.59

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Axsome Therapeutics

Vanguard Group
Fairmount Funds Management
BVF
Citadel Advisors
Perceptive Advisors
RA Capital Management
Millennium Management
Point72 Asset Management
Alethea Capital Management
Bellevue Group
Partner Fund Management
Avidity Partners Management
Boxer Capital
Eventide Asset Management
Tang Capital Management

View all funds holding Axsome Therapeutics